Outlook Therapeutics (OTLK)

Outlook Therapeutics (OTLK) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• OTLK last traded at $0.47, -5.15% on the day.
• Outlook Therapeutics: market cap $113.96M, P/E -0.4, revenue -$1.16M over the last four quarters, next earnings 2026-12-18.
• Over the past year OTLK returned -62.25%; year to date -70.37%.

Updated 2026-11-03 02:01 UTC